Morning Headlines 1/3/19
Health Level Seven International publishes the FHIR Release 4 standard.
Bristol-Myers Squibb to buy Celgene in $74 billion deal
The merger, if approved by shareholders and regulators, will create the US’s fourth-largest drug company.
Healthcare AI vendor Jvion raises a growth equity investment of an unstated amount, led by JMI Equity.
FDA guidance regarding SaMD is confusing and a distinction without a difference. Either just bite the bullet and classify all…